Submitted by Marilene Donadel (marilene.donadel@unioeste.br) on 2018-11-12T22:46:53Z No. of bitstreams: 1 Elaine_Witt_2018.pdf: 2791531 bytes, checksum: 048d2ad0555e9f07d9ad80e05214ce75 (MD5) / Made available in DSpace on 2018-11-12T22:46:56Z (GMT). No. of bitstreams: 1 Elaine_Witt_2018.pdf: 2791531 bytes, checksum: 048d2ad0555e9f07d9ad80e05214ce75 (MD5) Previous issue date: 2018-09-11 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Biodiesel is a sensible fuel to the oxidation, because it presents in its chemical composition some free radicals. To raise its oxidative stability it is necessary to add synthetic or natural antioxidants. Among the natural antioxidants there is a variety of plants that may be used with the function to avoid or to detain the chain reactions of oxidation, which are capable to promote or inactivate the free radicals interrupting the reaction in the biofuel chain. In the pomegranate peel is possible to detect some phenolic compounds and antioxidants compounds beyond several bioactive compounds with some mechanisms of action that are similar to the vitamin C, vitamin E and beta-carotene. The aim of this study was to evaluate the biodiesel oxidative stability in the presence of some natural oxidants which were extracted from the pomegranate peel by the conventional method of extraction (Soxhlet and the grease and oils extractor – Goldfish) and by the supercritical extraction with CO2 in a condition of constant pressure (200 bar), some variation in the temperature (35, 45 and 55 oC) and in the presence of the cosolvent ethanol (0, 2,5 and 5 mL). The extracts were measured in relation to the antioxidant activity by the DPPH• radical inhibition. The extract obtained by the Soxhlet method with ethyl acetate presented 94,16% of inhibition in the 1000 µg.mL-1 concentration. The phenolic compound content was used with the FolinCiocalteu reagent, which was evaluated for the extracts. The sample obtained by the grease and oils extractor – Goldfish with an ethanol solvent, showed a density of 98,62mg of EAG/g of the extract. The commercial biodiesel was additive with some extract of the pomegranate peel and with the synthetic antioxidants BHA and BHT and submitted to the oxidative stability test in the Rancimat. A test that indicates the time of the oxidation in the Exploratory Differential Calorimetry (DSC) equipment. It was analyzed the effects in the temperature and the addition of the ethanol cosolvent in the extract yield. The best tenses of induction obtained were for the additive biodiesel with some extracts obtained by the conventional method, both with the ethyl acetate solvent, which took 11,13 hours for the extract obtained in the grease and oils extractor (ExtAcet) and 11,01 hours for the extract obtained in the Soxhlet (SoxAcet). It was checked that these values are higher than the other ones which were found for the additive biodiesel with the synthetic antioxidants BHA (6,91h) and BHT (7,86). Among the extracts obtained by the supercritical extraction, it was highlighted the condition of 35 °C with 5 mL of ethanol (8,01 h) and 55 °C with 5 mL of ethanol (7,77 h).Except the supercritical extract in the temperature of 35 oC without the addition of ethanol, all the extracts presented a time of induction higher than the obtained in the control (4,38 h), however only threeextracts that were added to the biodiesel showed a higher value which is demanded in the Resolution n45/2014 and it predicts oxidative stability of 8h for the test in Rancimat. For the DSC test, the samples that presented a higher time of oxidation were for the ExtAcet (31,42 min) and the supercritical extraction in the condition of 35 °C with 5mL of ethanol (31,25 min). The biodiesel oxidative stability was in the most part higher when it was added to thepomegranate peel in comparison to the pure biodiesel showing efficiency in its utilization as a natural antioxidant. / Biodiesel é um combustível sensível a oxidação devido a sua composição química. Para elevar sua estabilidade termo oxidativa é necessário acrescentar antioxidantes sintéticos ou naturais. Dentre os antioxidantes naturais existe uma variedade de plantas que podem ser utilizadas com a finalidade de evitar ou retardar reações de oxidação. Estes são capazes de promover ou inativar os radicais livres interrompendo a reação em cadeia de oxidação do biocombustível. Na casca de romã é possível encontrar compostos fenólicos, compostos antioxidantes além de diversos compostos bioativos, com mecanismo de ação semelhante ao da vitamica C, Vitamina E e betacaroteno. O objetivo deste trabalho foi avaliar a estabilidade oxidativa do Biodiesel na presença de antioxidantes naturais extraídos da casca da romã pelo método de extração convencional (Soxhet e extrator de óleos e gorduras-Goldfish) e pela extração Supercrítica com CO2 supercrítico em condições de pressão constante (200 bar) e variação de temperatura (35, 45 e 55 oC) e cossolvente etanol (0 mL, 2,5 mL e 5 mL). Os extratos foram avaliados quanto à atividade antioxidante pela inibição do radical DPPH•, sendo o extrato obtido pelo método Soxhlet com acetato de etila o que apresentou 94,16% de inibição na concentração de 1000 µg.mL-1. O Teor de Compostos Fenólicos utilizando o reagente FolinCiocalteu foi avaliado para os extratos e a amostra obtida pelo equipamento extrator de óleos de gorduras-Goldfish com solvente etanol apresentou uma concentração de 98,62 mg de EAG/g de extrato. O biodiesel comercial foi aditivado com os extratos de casca de romã e com os antioxidantes sintéticos BHA e BHT e submetidos ao teste de estabilidade oxidativa em Rancimat e teste para indicar o tempo de oxidação em equipamento de Calorimetria Diferencial Exploratória (DSC). Foram avaliados os efeitos da temperatura e da adição de cossolvente etanol no rendimento do extrato. Os melhores tempos de indução obtidos foram para o Biodiesel aditivado com os extratos obtidos pelo método convencional, ambos com solvente acetato de etila, sendo 11,13 horas para o extrato obetido no extrator de óleos e gorduras (ExtAcet) e 11,01 horas para o SoxAcet. Ainda verificou-se que esses valores são superiores aos encontrados para o biodiesel aditivado com os antioxidantes sintéticos BHA (6,91 h) e BHT (7,86 h). Entre os extratos supercríticos destacou-se a condição de 35 °C com 5 mL de etanol (8,01 h) e 55 °C com 5 mL de etanol (7,77 h). Com exceção do extrato supercrítico na temperatura de 35 oC sem adição de etanol, todos os extratos apresentaram um tempo de indução superior ao obtido no controle (4,38 h), no entanto apenas três extratos aditivados ao biodiesel apresentaram valor superior ao exigido pela Resolução 45/2014 a qual prevê estabilidade oxidativa de 8 horas para o teste em Rancimat. Para o teste DSC, as amostras que apresentaram maior tempo de oxidação foi para o ExtAcet (31,42 min) e extração supercrítica na condição de 35 °C com 5 mL de etanol (31,25 min). A estabilidade oxidativa do biodiesel foi, em sua maioria, superior quando acrescido dos extratos de casca de romã, em comparação ao biodiesel puro, mostrando eficiência na sua utilização como antioxidante natural.

Orientador: Lireny Aparecida Guaraldo Gonçalves / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Engenharia de Alimentos / Made available in DSpace on 2018-08-19T08:12:03Z (GMT). No. of bitstreams: 1 DiazGamboa_OscarWilfredo_D.pdf: 1876345 bytes, checksum: 56e9f8f4f7650f56a9f3dd8d60c68957 (MD5) Previous issue date: 2011 / Resumo: O presente projeto visou estabelecer condições ideais de obtenção de um produto que poderá ser disponibolizado para comercialização no Brasil tendo como foco a encapsulação para aplicação na área alimentícia. Tocoferóis são antioxidantes naturais que podem ser utilizados para enriquecimento de alimentos. Contudo há a necessidade de proteção desse agente ativo por métodos especiais como a microencapsulação. No presente estudo foram desenvolvidos sistemas compostos por micropartículas obtidas por ¿spray chilling" utilizando lipídios interesterificados sem isômeros trans com óleo de soja totalmente hidrogenado na relação de 70:30% m/m respectivamente, com ponto de fusão na faixa de 40-65 °C para formação das matrizes. Alfa-tocoferol foi utilizado como principio ativo a ser encapsulado. Para a obtenção das micropartículas matrizes lipídicas foram fundidas e mantidas em banho à temperatura de 65 °C . O a-tocoferol foi adicionado nas misturas lipídicas que em seguida foram homogeinizados em ultraturrax. As soluções foram pulverizadas em atomizador duplo fluido aquecido também a 65 °C e pressão de ar de 0,25 MPa, com a a tomização efetuada dentro de uma câmara resfriada a 10 °C. Foi realizado um p lanejamento DCCR (Delineamento Central Rotacional) com 2 variáveis independentes: a velocidade de homogeneização (3000 a 11000 rpm) e a concentração de tocoferol (5-25 g/100g). A quantificação do princípio ativo encapsulado foi realizada utilizando técnica isocrática de cromatografia líquida de alta eficiência (CLAE). Os tratamentos foram caracterizados em relação à eficiência de encapsulação, morfologia, tamanho médio, estabilidade e liberação do princípio ativo. Para o estudo da estabilidade os tratamentos foram submetidos à estocagem por 180 dias em três diferentes temperaturas (ambiente 25°C ±5 °C, em estufa 22 °C e freezer a -18°C). Medidas de difração de raios-X (0 , 60, 120, 180 dias) e medidas calorimétricas (tempo zero) foram efetuadas. Foi realizada a incorporação das micropartículas em um produto comercial (Iogurte), que foi avaliado sensorialmente. De forma geral, as partículas lipídicas obtidas neste trabalho apresentaram bons resultados quanto à eficiência de encapsulação e apresentando forma esférica, com paredes contínuas, porém rugosas. Os termogramas, obtidos por calorimetria diferencial de varredura (DSC), em tempo zero, não apresentaram diferenças entre os ensaios. Os difratogramas foram muito semelhantes entre os tratamentos e constatou-se a presença de 3 picos principais que parecem estar associados à forma polimórfica ß. As micropartículas de liberação apresentaram boa capacidade de controle da liberação do composto ativo, mostrando-se potenciais para o uso futuro na indústria de alimentos. Finalmente os resultados da análise sensorial de aceitação não foram estatisticamente significativos para os atributos avaliados / Abstract: This project aimed to establish optimal conditions for obtaining a product that will be commercially available in Brazil, focusing on encapsulation for use in the food industry. Tocopherols are natural antioxidants that can be used for food enrichment.However, there is the need for protection of active agent by special methods, such as microencapsulation. The present study developed systems composed of microparticles obtained by "spray chilling" using an interesterified fat with no trans isomers with fully hydrogenated soybean oil in the ratio of 70:30% w/w respectively, with a melting point in the range of 40-65°C for the formation of matrices to encapsulate a-tocopherol as active principle.To obtain small particles a lipid matrices were melted in a water bath at a temperature of 65°C. The a-tocopherol was added to the lipid mixtures and then homogenized in Ultra Turrax for 5 min.The solutions were sprayed in double-fluid atomizer also heated to 65°C and air pressure of 0.25 MPa, the atomization performed inside a chamber cooled to 10°C. Were conducted a CCR design (Central Compo site Rotational Design) with two independent variables: the speed of homogenization (3000 to 11000 rpm) and the concentration of tocopherol (5-25 g/100 g).The quantification of the active ingredient encapsulated was performed using isocratic HPLC technique. The treatments were characterized with respect to encapsulation efficiency, morphology, average size and stability of the microparticles and release of active ingredient.For the stability study treatments were subjected to storage for 180 days at three different temperatures (ambient 25°C ± 5°C , 22°C in an oven and freezer -18°C).Since x-rays diffraction measurements (0, 60, 120, 180 days) and calorimetric measurements (time zero) were made. Were performed the incorporation of the microparticles in a commercial product (yogurt), which was evaluated using the sensory evaluation.In general, the lipid particles studied in this work showed good results in terms of encapsulation efficiency showing spherical shape, with solid rough walls. The thermograms obtained by DSC at time zero did not differ between trials.The XRD patterns were very similar among treatments and found the presence of three major peaks that are associated with the polymorphic form ß. The microparticles showed good ability to control the release of the active principle, showing potential for future use in the food industry. Finally the results of an smooth sensory acceptance indicated that the tested samples did not differ statistically from the standard sample for evaluated attributes / Doutorado / Tecnologia de Alimentos / Doutor em Tecnologia de Alimentos

Submitted by Biblioteca da Faculdade de Farmácia (bff@ndc.uff.br) on 2017-03-13T18:50:12Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Duarte, Letícia de Souza Guimarães [Dissertação, 2016].pdf: 2499210 bytes, checksum: 961dab593ba2ea593fadba0a224c15cc (MD5) / Made available in DSpace on 2017-03-13T18:50:12Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Duarte, Letícia de Souza Guimarães [Dissertação, 2016].pdf: 2499210 bytes, checksum: 961dab593ba2ea593fadba0a224c15cc (MD5) / A papaína, que corresponde a um complexo de enzimas extraídas do vegetal Carica papaya L., tem sido utilizada pela sua propriedade proteolítica em desbridamento enzimático de feridas. Diversos estudos descrevem o uso da papaína na forma de pó, solução, gel e creme sobre feridas, porém a baixa estabilidade da enzima nesses meios limita sua utilização em larga escala. O objetivo principal do trabalho consiste em desenvolver e avaliar formulações de papaína 10%(p/p) em gel carbômero, contendo antioxidantes como acetato de alfa-tocoferol e metabissulfito de sódio, associados a outros adjuvantes que permitam melhor estabilidade da enzima. As formulações iniciais para o estudo foram planejadas segundo desenho experimental fatorial 23, sendo as variáveis independentes representadas pelas concentrações de cisteína, de polissorbato 80 e de antioxidante (acetato de alfa-tocoferol ou metabissulfito de sódio). As amostras, mantidas sob refrigeração (5°C ± 3) por 7 dias, foram submetidas a ensaios de espectrofluorimetria para avaliação da atividade enzimática. Os resultados iniciais revelaram que as amostras que continham metabissulfito de sódio associado às maiores concentrações de polissorbato 80, apresentaram as melhores condições para manutenção da atividade proteolítica, enquanto que as amostras contendo alfa-tocoferol não foram capazes de manter a atividade. Sendo assim, realizou-se estudo de estabilidade com preparações contendo concentrações fixas de papaína 10% (p/p), polissorbato 80 2,0% (p/p), com variações nas concentrações de cisteína de 0,10, 0,13 e 0,16% (p/p) e metabissulfito de sódio de 0,50, 0,75 e 1,00% (p/p). Durante o período estudado, as amostras apresentaram aspecto homogêneo, sem mudanças na coloração e no odor. Na avaliação de pH não houve variação significativa dos valores (p>0,05). A variação de potencial Zeta foi menor que ǀ10ǀmV, não havendo diferença estatisticamente significativa em função do tempo (p>0,05). A partir dos resultados obtidos, novo desenho fatorial 23 foi traçado considerando como variáveis independentes: o tempo, as concentrações de metabissulfito e de cisteína. A presença de metabissulfito 0,5% ou 1,0% (p/p) associado a cisteína 0,16%(p/p) e polissorbato 80 2,0% (p/p), proporcionaram os menores valores de decaimento na concentração de papaína ativa nas formulações testadas por 28 dias. / Papain, which corresponds to a complex of enzymes from the plant Carica papaya L., has been used for its proteolytic property in enzymatic wound debridement. Several studies describe the use of papain as powder, solution, gel and cream forms over wounds; however, the low stability of the enzyme in the media limits its use in large scale. The main objective of this work is to develop and evaluate formulations with papain 10% (w/w) at carbomer gel, containing antioxidants as alpha-tocopherol acetate and sodium metabisulphite, associated with other adjuvants that enable better stability of the enzymes. The early formulations for the study were planned in a factorial experimental design 23, with the independent variables represented by cysteine, polysorbate 80 and antioxidant (alpha-tocopherol or sodium metabisulphite) concentrations. The samples, kept under refrigeration (5°C ± 3) for 7 days, were submitted to spectrofluorimetry essays for enzyme activity evaluation. Initial findings showed that the samples containing sodium metabisulphite associated with higher concentrations of polysorbate 80, presented the best conditions for proteolytic activity maintenance, whereas the samples containing alpha-tocopherol were not able to maintain activity. Thus, stability study was carried out with preparations with fixed concentrations of papain 10% (w/w), polysorbate 80 2.0% (w/w), with variations in the concentrations of cystein 0.10, 0.13 and 0.16% (w/w) and sodium metabisulphite 0.50, 0.75 and 1.00% (w/w). During the studied period, the samples showed a homogeneous appearance, without color or odor changes. At pH evaluation there was no significant change in values (p> 0.05). Zeta potential have varied less than |10|mV, with no statistically significant difference over time (p> 0.05). From the results, a new factorial design 23 was traced, considering as independent variables: time, metabisulphite and cystein concentrations. The presence of metabisulphite 0.5 % or 1.0 % (w/w) associated with cysteine 0.16 % (w/w), and polysorbate 80 2.0% (w/w), showed the lowest decay values of active papain concentration in the formulations tested for 28 days.

Background: Studies of gingival bleeding and the effects of antioxidants on extracellular matrix and immunologic and inflammatory responses provide a rationale for hypothesizing that antioxidants reduce the risk for gingival bleeding.Methods: This study evaluated the role of antioxidants as contributing risk factors for gingival bleeding utilizing the Third National Health and Nutrition Examination Survey (NAHNES III). A sample of 18,825 adults (20 to ≥ 90 years of age), with dental measurement and assessment of serum levels of antioxidants were included in the study. Gingival bleeding was defined as those who had more than 30 percent of gingival bleeding in 28 sites examined. SPSS version 11.0 software and Epi-info 2000 were used to perform the statistical analysis.Results: Using multiple logistic regression in five separate antioxidants, the study showed an association between increased plasma levels of vitamin C (ascorbic acid) and decreased risk for gingival bleeding (OR= 0.33; 95% CI 0.15 to 0.72). An inverse relationship was also found between gingival bleeding and serum levels of beta carotene (OR=1.93; 95% CI 1.05 to 3.54). However, negative association was found between gingival bleeding and vitamin A (OR=2.60; 95% CI 1.04 to 6.50). No statistically significant association was observed between gingival bleeding and serum levels in vitamin E (alpha tocopherol) and selenium.Conclusion: Antioxidants, vitamin C, vitamin A, and beta carotene, were significant risk factors for gingival bleeding. This should be emphasized for improving the oral health of the U.S. adult population.

Made available in DSpace on 2016-01-26T12:51:52Z (GMT). No. of bitstreams: 1 paulo saad_tese.pdf: 455472 bytes, checksum: 76fed03b80932ea6f964693d4c8d92cf (MD5) Previous issue date: 2006-06-19 / Cigarettes accounts for the death of millions of people a year worldwide, directly related to lung cancer. Some studies have shown that larger plasmatic indexes of beta-carotene or a great ingestion of foods rich in carotenoids diminish the risk of developing this neoplasia. On the other hand, studies suggest that the smokers' lung can alter the metabolism of beta-carotene, that is, producing greater risk of cell alterations and neoplasias. It is probable that the alpha-tocopherol has beneficial effect on this association. Objective: To evaluate the participation of beta-carotene and alpha-tocopherol in the development of lung cancer induced by urethane and its relationship with cigarette exposition. Material and Method: Balb C mice were divided into 10 groups: G1(cigarette), G2 (cigarette and urethane), G3 (only urethane), G4, G5 and G6 (cigarette, urethane and beta-carotene to 0.25, 0.05 and 0.005%, respectively), G8 (urethane and beta-carotene to 0.25%), G7, G10 and G11 (cigarette, urethane and beta-carotene to 0.25 and alpha-tocopherol 0.25; 0.05 and 0.005%, respectively).The exposition to the cigarette was for 10 minutes, twice a day, 5 days a week, during 16 weeks. For induction of tumors, urethane was administered intraperitonealy, in the dose of 3.0mg/Kg. Nodules and hyperplasias were quantified; morphometric analyses of the nodules were performed. Kruskal-Wallis and of Mann-Whitney tests were used for statistical analysis. Results: Group G3 presented greater number of nodules (P=0.001), smaller stromal fraction (P=0.011) and greater sum of the tumor area (P=0.047) compared to group G2. Group G8 showed smaller number of nodules (P=0.013) and hyperplasias (P=0.05) compared to group G3. Both smaller doses of beta-carotene (G5 and G6) were statistically similar, although with smaller number of nodules when compared to group G4 (P=0.04). Group G4 presented smaller number of hyperplasias than G8, however, the number of nodules did not alter (P=0.045%). Stromal fraction of groups G3 and G4 was similar, although smaller than G2 and G5 (P=0.011). According to the alpha-tocopherol, the stromal fraction of group G7 was greater than the one of the groups G2, G3, G4 and G10 (P=0.011). The 0.25%-beta-carotene diet increased the area of the nodules, demonstrated by the largest area (P=0.03), smaller area (P=0.03), sum of the areas (P=0.018) and average of the areas (P=0.006) in group G4 when compared to G2. Conclusion: According to these results, it was concluded that passive tobacco can be a protecting factor in the evolution of tumors induced by urethane in mice, however, there is no evidence that this could be dose-dependent. The supplementation of beta-carotene in 0.25%-dose can also be a protecting factor, however, associated to passive tobacco it has smaller effect than in lower doses (0.05 and 0.005%). The exposition to cigarette smoke does not alter the number of nodules induced by urethane in mice when in the presence of 0.25%-beta-carotene diet; however the hyperplasia number with the presence of the cigarette diminished. The association of the alpha-tocopherol to the 0.25%- beta-carotene and the passive tobacco produces a protecting factor, mainly in the dose of 0.25%. / O hábito de fumar cigarros é responsável pela morte de milhões de pessoas por ano em todo o mundo, estando diretamente relacionado ao câncer de pulmão. Estudos demonstraram que maiores índices plasmáticos de beta-caroteno ou a grande ingestão de alimentos ricos em carotenóides diminuem o risco de desenvolver esta neoplasia. Por outro lado, existem estudos que sugerem que o pulmão de fumantes pode alterar o metabolismo do beta-caroteno, gerando maior risco de alterações celulares e neoplasias. É provável que o alfa-tocoferol tenha efeito benéfico sobre esta associação. Objetivo: Avaliar a participação do beta caroteno e do alfa-tocoferol no desenvolvimento de câncer de pulmão induzido por uretana e sua relação com a exposição ao cigarro. Material e Método: Camundongos Balb C foram divididos em 10 grupos: G1(cigarro), G2(cigarro e uretana), G3 (uretana), G4, G5 e G6 (cigarro, uretana e beta-caroteno a 0,25; 0,05 e 0,005% respectivamente), G8 (uretana e Beta-caroteno a 0,25%), G7, G10 e G11 (cigarro, uretana e beta-caroteno a 0,25 e alfa-tocoferol a 0,25; 0,05 e 0,005% respectivamente). A exposição ao cigarro ocorreu durante 10 minutos, 2 vezes por dia, 5 dias por semana, por 16 semanas. Para a indução de tumores, foi administrada uretana por via intraperitoneal na dose de 3,0mg/Kg. Foram quantificados nódulos e hiperplasias, realizada análise morfométrica dos nódulos e submetidos aos testes de Kruskal-Wallis e de Mann-Whitney para análise estatística. Resultados: O grupo G3 apresentou maior número de nódulos (P=0,001), menor fração estromal (P=0,011) e maior soma da área de tumor (P=0,047) comparado ao grupo G2. O grupo G8, mostrou-se com menor número de nódulos (P=0,013) e hiperplasias (P=0,05) comparados ao grupo G3. As duas doses menores de beta-caroteno (G5 e G6) se mostraram estatisticamente semelhantes, porém com menor número de nódulos quando comparados ao grupo G4 (P=0,04). O grupo G4 apresentou menor número de hiperplasias que G8, porém o número de nódulos não se alterou (P=0,045). A fração estromal dos grupos G3 e G4 foram semelhantes, porém menores que G2 e G5 (P=0,011). Quanto ao alfa-tocoferol, a fração estromal do grupo G7 foi maior que a dos grupos G2, G3, G4 e G10 (P=0,011). A dieta com beta-caroteno a 0,25% aumentou a área dos nódulos, demonstrada pela maior área (P=0,03), menor área (P=0,03), soma das áreas (P=0,018) e média das áreas (P=0,006) no grupo G4 comparada com o grupo G2. Conclusão: Com estes resultados, concluiu-se que na evolução de tumores induzidos por uretana em camundongos o fumo passivo se comporta como um fator protetor, porém não há evidência de que seja dose-dependente. A suplementação de beta-caroteno na dose de 0,25% também age como protetor, porém associada ao fumo passivo tem efeito menor do que em doses mais baixas (0,05 e 0,005%). A exposição à fumaça do cigarro não altera o número de nódulos quando na presença de dieta com beta-caroteno a 0,25%, porém o número de hiperplasias com a presença do cigarro diminui. A associação do alfa-tocoferol ao beta-caroteno 0,25% e ao fumo passivo gera um fator protetor, principalmente na dose 0,25%.

Vitamin E was first described in 1922 as an unknown factor required for impregnated rats to carry their offspring to term. In fact, when vitamin E was chemically characterized it was given the name "tocopherol" derived from the Greek: tokos = childbirth; phero = to bear; and –ol, indicating an alcohol. Vitamin E is linked to animal health and wellness, maternal fertility and a human neurodegenerative condition, ataxia with vitamin E deficiency However, embryonic vitamin E requirements during development remained unknown. We hypothesized that vitamin E is critical, not only for the mother, but specifically by the embryo for proper development. To separate the embryonic and maternal requirements, we employed an innovative model for the study of vitamin E: the zebrafish. We began by formulating and testing the first fully defined diet sufficient for zebrafish health. We then removed vitamin E from the formula to create our E deficient (E-) diet, which, when fed to adult zebrafish (for >3 months), resulted in E- adults that produced viable, E- gametes. Deficient embryos initially developed normally; however, by 48 hours post fertilization (hpf), E- embryos developed severe malformations leading to significant mortality. Thus, we demonstrated for the first time an embryonic vitamin E requirement. We provided further insight into the embryonic vitamin E requirement by analyzing the transcriptional changes occurring prior to the observed malformations. The transcriptome revealed a putative mechanism of action for vitamin E in development, in which vitamin E deficiency leads to the dysregulation of key metabolic co-activators. Finally, to understand the trafficking of vitamin E, we identified the zebrafish α-tocopherol transfer protein (TTP). We demonstrated that the zebrafish TTP is homologous to its human counterpart, and its expression is both spatially and temporally regulated during embryonic development. Knocking down the expression of TTP, using morpholinos injected at the one-cell stage, resulted in early and severe malformations in the developing head and tail. Consequently we revealed a definitive role for TTP during development. Taken together the work described here presents a new direction for future research into the role of vitamin E and TTP in post-implantation development. / Graduation date: 2012

Vitamin E wird immer noch als das wichtigste lipophile Antioxidanz in biologischen Membranen betrachtet. In den letzten Jahren hat sich jedoch der Schwerpunkt der Vitamin E-Forschung hin zu den nicht-antioxidativen Funktionen verlagert. Besonderes Interesse gilt dabei dem α-Tocopherol, der häufigsten Vitamin E-Form im Gewebe von Säugetieren, und seiner Rolle bei der Regulation der Genexpression. Das Ziel dieser Dissertation war die Untersuchung der genregulatorischen Funktionen von α-Tocoperol und die Identifizierung α-Tocopherol-sensitiver Gene in vivo. Zu diesem Zweck wurden Mäuse mit verschiedenen Mengen α-Tocopherol gefüttert. Die Analyse der hepatischen Genexpression mit Hilfe von DNA-Microarrays identifizierte 387 α-Tocopherol-sensitive Gene. Funktionelle Clusteranalysen der differentiell exprimierten Gene zeigten einen Einfluss von α-Tocooherol auf zelluläre Transportprozesse. Besonders solche Gene, die an vesikulären Transportvorgängen beteiligt sind, wurden größtenteils durch α-Tocopherol hochreguliert. Für Syntaxin 1C, Vesicle-associated membrane protein 1, N-ethylmaleimide-sensitive factor and Syntaxin binding protein 1 konnte eine erhöhte Expression mittels real time PCR bestätigt werden. Ein funktioneller Einfluss von α-Tocopherol auf vesikuläre Transportprozesse konnte mit Hilfe des in vitro β-Hexosaminidase Assays in der sekretorischen Mastzelllinie RBL-2H3 gezeigt werden. Die Inkubation der Zellen mit α-Tocopherol resultierte in einer konzentrationsabhängigen Erhöhung der PMA/Ionomycin-stimulierten Sekretion der β-Hexosaminidase. Eine erhöhte Expression ausgewählter Gene, die an der Degranulation beteiligt sind, konnte nicht beobachtet werden. Damit schien ein direkter genregulatorischer Effekt von α-Tocopherol eher unwahrscheinlich. Da eine erhöhte Sekretion auch mit β-Tocopherol aber nicht mit Trolox, einem hydrophilen Vitamin E-Analogon, gefunden wurde, wurde vermutet, dass α-Tocopherol die Degranulation möglicherweise durch seine membranständige Lokalisation beeinflussen könnte. Die Inkubation der Zellen mit α-Tocopherol resultierte in einer veränderten Verteilung des Gangliosids GM1, einem Lipid raft Marker. Es wird angenommen, dass diese Membranmikrodomänen als Plattformen für Signaltransduktionsvorgänge fungieren. Ein möglicher Einfluss von Vitamin E auf die Rekrutierung/Translokation von Signalproteinen in Membranmikrodomänen könnte die beobachteten Effekte erklären. Eine Rolle von α-Tocopherol im vesikulären Transport könnte nicht nur seine eigene Absorption und seinen Transport beeinflussen, sondern auch eine Erklärung für die bei schwerer Vitamin E-Defizienz auftretenden neuronalen Dysfunktionen bieten. Im zweiten Teil der Arbeit wurde die α-Tocopheroltransferprotein (Ttpa) Knockout-Maus als genetisches Modell für Vitamin E-Defizienz verwendet, um den Effekt von Ttpa auf die Genexpression und die Gewebeverteilung von α-Tocopherol zu analysieren. Ttpa ist ein cytosolisches Protein, das für die selektive Retention von α-Tocopherol in der Leber verantwortlich ist. Die Ttpa-Defizienz resultierte in sehr geringen α-Tocopherol-Konzentrationen im Plasma und den extrahepatischen Geweben. Die Analyse der α-Tocopherol-Gehalte im Gehirn wies auf eine Rolle von Ttpa bei der α-Tocopherol-Aufnahme ins Gehirn hin. / Vitamin E is still considered the most important lipid-soluble antioxidant within biological membranes. However, in the last years the non-antioxidant functions of vitamin E have become the focus of vitamin E research. From the eight members of the vitamin E family, specific emphasis is given to α-tocopherol, the most abundant vitamin E form in mammalian tissues, and its role in the regulation of gene expression. The aim of this thesis was the analysis of the gene regulatory functions of α-tocopherol and the identification of α-tocopherol sensitive genes in vivo. For this purpose mice were fed diets differing in α-tocopherol content. The analysis of hepatic gene expression using DNA microarrays identified 387 α-tocopherol-sensitive genes. Functional cluster analyses of these differentially expressed genes demonstrated an influence of α-tocopherol on cellular transport processes. Especially the expression of genes involved in vesicular trafficking was largely upregulated by α-tocopherol. Upregulation of syntaxin 1C, vesicle-associated membrane protein 1, N-ethylmaleimide-sensitive factor and syntaxin binding protein 1 was verified by real time PCR. A role of α-tocopherol in exocytosis was shown by the in vitro β-hexosaminidase release assay in the secretory mast cell line RBL-2H3. Incubation with α-tocopherol resulted in a concentration dependent increase of PMA/ionomycin-stimulated secretion of β-hexosaminidase. Induction of selected genes involved in degranulation was not observed at any time point. Thus, a direct gene-regulatory effect of α-tocopherol seemed rather unlikely. Since increased secretion was also observed with ß-tocopherol but not with trolox, a water-soluble analog of vitamin E, it was hypothesized that α-tocopherol might affect degranulation through its localization at the plasma membrane. Incubation of cells with α-tocopherol changed the distribution of the gangliosid GM1, a Lipid raft marker. These membrane microdomains are assumed to function as signaling platforms. An possible influence of vitamin E on the recruitment/translocation of signaling proteins into membrane microdomains could explain the observed effects. A role of α-tocopherol in the vesicular transport might not only affect its own absorption and transport but also explain the neural dysfunctions observed in severe α-tocopherol deficiency. In the second part of this dissertation the α-tocopherol transfer protein (Ttpa) knockout-mouse as a model of genetic vitamin E deficiency was used to analyze the effect of Ttpa gene expression and tissue distribution of α-tocopherol. Ttpa is a cytosolic protein, which is responsible for the selective retention of α-tocopherol in the liver. Its deficiency resulted in very low α-tocopherol concentrations in plasma and extrahepatic tissues. Analysis of α-tocopherol contents in brain indicated a role for Ttpa in the uptake of α-tocopherol into the brain.

Diet and oral supplements comprise two distinct sources of antioxidants known to prevent oxidative stress. Beneficial effects from antioxidants have been seen for patients at risk for type 2 diabetes. The aim of this thesis was to evaluate the positive effects of antioxidants against oxidative stress and DNA damage in type 2 diabetes subjects. We also used antioxidants as tools to determine the mechanisms behind genotoxicity induced by mutagenic pro-oxidative agents in mouse lymphoma cells. Several techniques were used to measure oxidative stress and DNA damage, but the main technique used was alkaline comet assay. The results showed that the fruit and vegetable intake was inversely related to oxidative stress in type 2 diabetes subjects. However, oral supplementary intake of 20 antioxidants did not decrease oxidative stress biomarkers. In studies on mouse lymphoma cells, using the alkaline comet assay, DNA damage was induced by catechol and o-phenylenediamine (OPD), while 4-nitro-o-phenylenediamine (4-NOPD) induced only oxidative damage, showing different mechanisms of action behind the mutagenicity of the compounds. Also, oxidative stress was induced by catechol and 4-NOPD, whereas imbalances in the nucleotide pool were seen after exposure to OPD or 4-NOPD. Addition of antioxidants together with these pro-oxidants showed that β-carotene was able to reduce DNA damage at low concentrations of catechol, but increased DNA damage at high concentration. In comparison, addition of α-tocopherol slightly decreased catechol-induced DNA damage at all concentrations of catechol. However, no effect of α-tocopherol was seen on OPD-or 4-NOPD-induced DNA damage. In conclusion, antioxidants from fruits and vegetables, but not from oral supplements, reduced oxidative stress in type 2 diabetes patients, suggesting fruits and vegetables being a healthier source for antioxidant-intake, as compared to oral supplements. Different mechanisms of action for mutagenic pro-oxidants were shown in mouse lymphoma cells, introducing the nucleotide pool as an interesting target for oxidative stress. Reduction of catechol-induced DNA damage by β-carotene or α-tocopherol was shown, with a pro-oxidative action of β-carotene at high concentration of catechol, Interestingly, α-tocopherol was not able to decrease OPD- or 4-NOPD-induced DNA damage, supporting different mechanisms of action behind the genotoxicity from the three pro-oxidants.

Made available in DSpace on 2015-07-22T20:49:58Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-09-30. Added 1 bitstream(s) on 2015-08-11T03:25:27Z : No. of bitstreams: 1 Publico-00264.pdf: 1668171 bytes, checksum: dbdf365617164c11a9a209e69d18f997 (MD5) / O ƒÑ-tocoferol tem sido o foco das pesquisas dentre os demais componentes da vitamina E por ser a forma predominantemente encontrada nos tecidos de mamiferos, e por possuir uma extensa gama de atividades biologicas. O ƒÑ-tocoferol pode atuar como regulador de enzimas especificas e de fatores de transcricao de forma a influenciar estruturas celulares como membranas e dominios lipidicos, desencadeando respostas celulares que muitas vezes se mostram independentes de sua funcao antioxidante. No sistema hematopoetico, seus efeitos foram favoraveis em casos de anemias hemoliticas, aumentando a resistencia dos eritrocitos a lise. Tambem foi observado que a suplementacao previa com ƒÑ-tocoferol a irradiacao resulta em aumento da sobrevida de camundongos por induzir aumento no numero de unidades formadoras de colonias (CFUs). Entretanto, os mecanismos biologicos ativados pelo ƒÑ-tocoferol nas celulas hematopoeticas ainda nao foram descritos. Assim, os bjetivos deste trabalho foram verificar os efeitos do ƒÑ-tocoferol na hematopoese murina e os mecanismos intracelulares relacionados a estes efeitos. Para tal, camundongos foram tratados intraperitonealmente com doses de 40 mg/kg/dia de ƒÑ-tocoferol durante 2 semanasem dias intercalados, sendo sacrificados 24 horas apos a ultima dose; condicoes estas que nao causaram toxicidade as celulas da medula ossea. Amostras histologicas dos femures dos animais que receberam o tratamento com ƒÑ-tocoferol apresentaram hiperplasia medular. O tratamento com ƒÑ-tocoferol induziu aumento na porcentagem das celulas progenitoras hematopoeticas (Lin-Sca-1+c-Kit+ e Lin-Sca-1-c-Kit+), assim como o aumento do estado proliferativo destas populacoes (com mais celulas primitivas na fase S/G2/M do ciclo celular), com o consequente aumento da capacidade de formar CFUs de granulocitos e macrofagos. Dentre as distintas populacoes de celulas maduras da medula ossea, houve um favorecimento da linhagem granulocitica/monocitica (Mac-1+Gr-1+) em detrimento das linhagens eritrociticas (Ter119+) e linfociticas (B220+ e CD3+). Como forma de avaliar o mecanismo de acao do ƒÑ-tocoferol, investigou-se tambem a ativacao das proteinas relacionadas com a sinalizacao das celulas hematopoeticas. Assim, observou-se que as populacoes primitivas medulares apresentaram uma menor ativacao da cinase regulada por sinais extracelulares 1/2 (ERK1/2), da proteina cinase C (PKC), do ¡§ativador de transcricao e transdutor de sinal ¡V 5¡§ (STAT-5), mas nao da proteina cinase B/Akt. Tambem foi verificado que a diminuicao do estado fosforilado da ERK1/2 ocorreu desde os primeiros dias de tratamento. Interessante destacar quer o ƒÑ-tocoferol potencializou o efeito da interleucina-3 (IL-3) sobre a ativacao da ativacao da ERK1/2 nas celulas primitivas hematopoeticas. O inibidor da MEK (PD98059) foi capaz de restabelecer as porcentagens normais das linhagens eritrocitica e granulocitica/monocitica, assim como os niveis normais da fosfo- ERK1/2, alem da resposta da ERK1/2 ao estimulo com IL-3. Entretanto, o PD98059 nao restabeleceu as porcentagens normais das celulas primitivas hematopoeticas, nem da linhagem linfocitica. A quantificacao das especies reativas de oxigenio nas diferentes populacoes da medula ossea mostrou que, nas condicoes de tratamento estabelecidas, o ƒÑ-tocoferol nao exerceu funcao proou antioxidante, pois nao houve alteracao significativa dos niveis de especies reativas de oxigenio entre os grupos controle e tratado com ƒÑ-tocoferol. Desta forma, foi mostrada uma nova propriedade do ƒÑ-tocoferol independente de sua acao redox: a inducao de hiperplasia na medula ossea pelo aumento dos progenitores hematopoeticos e favorecimento da diferenciacao destes em granulocitos e macrofagos, pela potencializacao da resposta da ERK1/2 ao estimulo com IL-3. / TEDE / BV UNIFESP: Teses e dissertações

Made available in DSpace on 2014-12-17T14:03:42Z (GMT). No. of bitstreams: 1 HeleniAC_DISSERT.pdf: 2512013 bytes, checksum: e69e375e25ebb38b43385a02d5ecc6c7 (MD5) Previous issue date: 2013-06-10 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / The Vitamin E consists of eight chemically homologous forms, designated alpha, beta, gamma and delta tocopherols and tocotrienols. Biologically, the alpha-tocopherol (α-TOH) is the most important. Commercially, are found two types of α-TOH a natural (RRR-alpha-tocopherol) and another synthetic (all-rac-alpha-tocopherol). Both forms are absorbed in the intestine, the liver is a preference in favor of forms 2R, due to transfer protein α-TOH. It has higher affinity to these stereoisomers. Newborns are considered high risk for vitamin E deficiency, mainly premature, these have breast milk as a food source for maintenance of serum α-TOH. Clinical signs such as thrombocytosis, hemolytic anemia, retrolental fibroplasia, intraventricular hemorrhage, bronchopulmonary dysplasia and spinocerebellar degeneration can be found in case of a low intake of α-TOH. Thus, maternal supplementation on postpartum with α-TOH can be an efficient way to increase levels of vitamin E in breast milk and thus the consequently increase the supply of micronutrient for the newborn. However, most studies with vitamin E supplementation have been conducted in animals and little is known about the effect of maternal supplementation in humans, as well as on its efficiency to increase levels of α-TOH in human milk, depending on the shape natural or synthetic. The study included 109 women, divided into three groups: control without supplementation (GC) (n=36), supplemented with natural capsule (GNAT) (n=40) and the synthetic capsule (GSINT) (n=33). Blood samples were collected for determination of maternal nutritional status, and colostrums at initial contact and after 24 hours post-supplementation. Analyses were performed by High Performance Liquid Chromatography. Values of α-TOH in serum below 499.6mg/dL were considered deficient. We used the Kruskal-Wallis test and Tukey test to confirm the increase of alpha-tocopherol in milk and efficiency of administered capsules. Daily consumption of α-TOH was based on daily intake of 500 mL of colostrum by the newborn and compared with the nutritional requirement for children from 0 to 6 months of age, 4 mg / day. The mothers had mean concentration of serum α-TOH in 1016 ? 52, 1236 ? 51 and 1083 ? 61 mg / dL, in CG, GNAT and GSINT respectively. There were no women with deficiiency. The GC did not change the concentrations of α-TOH in colostrum. While women supplemented with natural and synthetic forms increased concentrations of α-TOH colostrum in 57.6% and 39%, respectively. By comparing supplemented groups, it was observed a significant difference (p=0.04), the natural capsule more efficient than the synthetic, approximately 49.6%. Individually, 21.1% of the women provided below 4mg/day of α-TOH, after supplementation for this index declined4.1%. Thus, maternal supplementation postpartum raised the levels of alpha-tocopherol in colostrum, and increased efficiency was observed with the natural form / A vitamina E consiste em oito formas quimicamente hom?logas, denominadas, alfa, beta, gama e delta, tocofer?is e tocotrien?is. Biologicamente, o alfa-tocoferol (α-TOH) ? o mais importante. Comercialmente s?o encontradas duas formas de α-TOH, uma natural (RRR-alfa-tocoferol) e outra sint?tica (all-rac-alfa-tocoferol). Ambas as formas s?o absorvidas no intestino, entretanto, no f?gado ocorre uma prefer?ncia em favor das formas 2R, devido ? prote?na de transfer?ncia de α-TOH, apresentar maior afinidade a estes estereois?meros. Os neonatos s?o considerados grupo de risco para defici?ncia de vitamina E, principalmente os pr?-maturos, estes t?m o leite materno como a fonte alimentar para manuten??o dos n?veis s?ricos de α-TOH. Sinais cl?nicos como trombocitose, anemia hemol?tica, fibroplasia retrolental, hemorragia intraventricular, displasia bronco pulmonar e degenera??o espinocerebelar podem ser encontrados caso ocorra uma baixa ingest?o de α-TOH. Sendo assim, a suplementa??o materna nos p?s-parto com α-TOH pode ser uma forma eficiente de aumentar os n?veis de vitamina E no leite materno e, consequentemente aumento no fornecimento do micronutriente para o rec?m-nascido. Entretanto, a maioria dos estudos com suplementa??o de vitamina E foram realizados em animais e s?o escassos os conhecimentos de sua suplementa??o em humanos, bem como, sobre sua efici?ncia para aumentar os n?veis de α-TOH no leite humano, em fun??o da forma natural ou sint?tica. Participaram do estudo 109 mulheres, distribu?das em tr?s grupos: controle sem suplementa??o (GC) (n=36), suplementadas com a c?psula natural (GNAT) (n=40) e com a c?psula sint?tica (GSINT) (n=33). Foram coletadas amostras de sangue para determina??o do estado nutricional materno, e de colostro no contato inicial e ap?s 24 horas p?s-suplementa??o. As an?lises foram realizadas por Cromatografia L?quida de Alta Efici?ncia. Valores de α-TOH no soro inferiores a 499,6 μg/dL foram considerados como deficientes. Foram utilizados o teste de Kruskal Wallis e teste de Tukey para confirmar o aumento de alfa-tocoferol no leite e a efici?ncia das c?psulas administradas. O consumo di?rio de α-TOH foi baseado na ingest?o di?ria de 500 mL de colostro pelo rec?m-nascido e comparada com o requerimento nutricional para crian?as de 0 ? 6 meses de idade, 4 mg/dia. As parturientes apresentaram concentra??o m?dia de α-TOH no soro de 1016 ? 52, 1236 ? 51 e 1083 ? 61 μg/dL, nos grupos GC, GNat e GSINT, respectivamente. N?o foram encontradas mulheres com defici?ncia. O GC n?o apresentou varia??o nas concentra??es de α-TOH no colostro. Enquanto mullheres suplementadas com as formas natural e sint?tica aumentaram as concentra??es de α-TOH no colostro em 57,6% e 39%, respectivamente. Ao comparar os grupos suplementados foi observado uma diferen?a significativa (p=0,04), sendo a c?psula natural mais eficiente que a sint?tica em aproximadamente 49,6%. Individualmente 21,1% das mulheres forneceram valores inferiores as 4mg/dia de α-TOH, ap?s a suplementa??o este ?ndice declinou para 4,1%. Sendo assim, a suplementa??o materna no p?s-parto elevou os n?veis de alfa-tocoferol no colostro e maior efici?ncia foi observada com a forma natural